Nuveen Asset Management, LLC Bridge Bio Pharma, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 445,936 shares of BBIO stock, worth $12.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

445,936

Previous 567,681 21.45%

Holding current value

$12.4 Million

Previous $14.4 Million 21.04%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$23.91 - $31.3 $2.91 Million - $3.81 Million	-121,745 Reduced 21.45%	445,936 $11.4 Million
Q2 2024 Aug 09, 2024	BUY	$23.0 - $31.04 $5.9 Million - $7.96 Million	256,322 Added 82.32%	567,681 $14.4 Million
Q1 2024 May 13, 2024	SELL	$27.35 - $40.45 $171,976 - $254,349	-6,288 Reduced 1.98%	311,359 $9.63 Million
Q4 2023 Feb 14, 2024	SELL	$24.02 - $43.89 $5.54 Million - $10.1 Million	-230,567 Reduced 42.06%	317,647 $12.8 Million
Q3 2023 Nov 14, 2023	SELL	$16.89 - $35.01 $6.09 Million - $12.6 Million	-360,457 Reduced 39.67%	548,214 $14.5 Million
Q2 2023 Aug 14, 2023	BUY	$13.29 - $18.01 $5.15 Million - $6.98 Million	387,594 Added 74.38%	908,671 $15.6 Million
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $1.22 Million - $3.16 Million	170,368 Added 48.58%	521,077 $8.64 Million
Q4 2022 Feb 14, 2023	SELL	$6.74 - $11.52 $127,082 - $217,209	-18,855 Reduced 5.1%	350,709 $2.67 Million
Q3 2022 Nov 14, 2022	SELL	$7.94 - $12.36 $2.31 Million - $3.6 Million	-291,267 Reduced 44.08%	369,564 $3.67 Million
Q2 2022 Aug 15, 2022	BUY	$5.21 - $12.14 $1,312 - $3,059	252 Added 0.04%	660,831 $6 Million
Q1 2022 May 16, 2022	BUY	$7.34 - $17.16 $2.12 Million - $4.96 Million	288,873 Added 77.72%	660,579 $6.9 Million
Q4 2021 Feb 14, 2022	SELL	$11.38 - $53.41 $2.2 Million - $10.3 Million	-193,668 Reduced 34.25%	371,706 $6.2 Million
Q3 2021 Nov 12, 2021	SELL	$46.87 - $64.24 $1.4 Million - $1.92 Million	-29,814 Reduced 5.01%	565,374 $26.5 Million
Q2 2021 Aug 16, 2021	BUY	$46.47 - $63.93 $7.33 Million - $10.1 Million	157,750 Added 36.06%	595,188 $36.3 Million
Q1 2021 May 17, 2021	BUY	$55.47 - $72.35 $6.38 Million - $8.32 Million	114,963 Added 35.65%	437,438 $26.9 Million
Q4 2020 Feb 16, 2021	SELL	$38.38 - $71.11 $6,371 - $11,804	-166 Reduced 0.05%	322,475 $22.9 Million
Q3 2020 Nov 16, 2020	SELL	$27.2 - $42.19 $287,721 - $446,285	-10,578 Reduced 3.17%	322,641 $12.1 Million
Q2 2020 Aug 14, 2020	SELL	$22.22 - $35.69 $1.23 Million - $1.98 Million	-55,429 Reduced 14.26%	333,219 $10.9 Million
Q1 2020 May 14, 2020	SELL	$16.11 - $36.23 $2.38 Million - $5.34 Million	-147,515 Reduced 27.51%	388,648 $11.3 Million
Q4 2019 Feb 14, 2020	BUY	$17.96 - $46.63 $8.06 Million - $20.9 Million	448,791 Added 513.66%	536,163 $18.8 Million
Q3 2019 Nov 14, 2019	BUY	$20.13 - $32.38 $1.76 Million - $2.83 Million	87,372 New	87,372 $1.88 Million

Others Institutions Holding BBIO

# of Institutions

291

Shares Held

171M

Call Options Held

10.4M

Put Options Held

2.37M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.11B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Bridge Bio Pharma, Inc. Transaction History